(NASDAQ: RXST) Rxsight's forecast annual revenue growth rate of 1.91% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.03%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.68%.
Rxsight's revenue in 2025 is $142,086,000.On average, 13 Wall Street analysts forecast RXST's revenue for 2025 to be $5,262,929,920, with the lowest RXST revenue forecast at $5,036,788,400, and the highest RXST revenue forecast at $5,457,000,461. On average, 13 Wall Street analysts forecast RXST's revenue for 2026 to be $5,616,121,858, with the lowest RXST revenue forecast at $4,944,275,960, and the highest RXST revenue forecast at $6,152,282,843.
In 2027, RXST is forecast to generate $6,234,927,290 in revenue, with the lowest revenue forecast at $5,399,437,165 and the highest revenue forecast at $7,270,244,285.